Sino Medical Sciences Technology Inc. (688108.SS)
CNY 10.24
(-0.49%)
CNY 10.24
(-0.49%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -44.14 Million CNY | 69.58% |
| 2022 | -145.11 Million CNY | 40.4% |
| 2021 | -243.48 Million CNY | 50.69% |
| 2020 | -493.74 Million CNY | 22.66% |
| 2019 | -638.38 Million CNY | -70.67% |
| 2018 | -374.05 Million CNY | -251.86% |
| 2017 | -106.3 Million CNY | -148.94% |
| 2016 | -42.7 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 36.45 Million CNY | 174.4% |
| 2024 Q1 | -49 Million CNY | -11.0% |
| 2024 Q3 | -117.09 Million CNY | -365.8% |
| 2023 Q4 | -44.14 Million CNY | 35.93% |
| 2023 FY | -44.14 Million CNY | 69.58% |
| 2023 Q3 | -68.9 Million CNY | 30.7% |
| 2023 Q2 | -99.43 Million CNY | -4.83% |
| 2023 Q1 | -94.85 Million CNY | 34.63% |
| 2022 Q4 | -145.11 Million CNY | -49.48% |
| 2022 Q2 | -130.92 Million CNY | 9.13% |
| 2022 Q1 | -144.07 Million CNY | 40.83% |
| 2022 Q3 | -97.07 Million CNY | 25.85% |
| 2022 FY | -145.11 Million CNY | 40.4% |
| 2021 Q2 | -309.98 Million CNY | 1.41% |
| 2021 Q1 | -314.41 Million CNY | 42.27% |
| 2021 FY | -243.48 Million CNY | 50.69% |
| 2021 Q4 | -243.48 Million CNY | -5.1% |
| 2021 Q3 | -231.67 Million CNY | 25.26% |
| 2020 Q4 | -544.66 Million CNY | -38.94% |
| 2020 Q3 | -392.02 Million CNY | 5.13% |
| 2020 Q2 | -413.2 Million CNY | -7.56% |
| 2020 Q1 | -384.16 Million CNY | 39.82% |
| 2020 FY | -493.74 Million CNY | 22.66% |
| 2019 Q4 | -638.38 Million CNY | -136.45% |
| 2019 FY | -638.38 Million CNY | -70.67% |
| 2019 Q3 | -269.98 Million CNY | 8.09% |
| 2019 Q1 | 382.21 Million CNY | 202.18% |
| 2019 Q2 | -293.74 Million CNY | -176.85% |
| 2018 Q4 | -374.05 Million CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | -374.05 Million CNY | -251.86% |
| 2017 FY | -106.3 Million CNY | -148.94% |
| 2016 FY | -42.7 Million CNY | 0.0% |